Search by Drug Name or NDC
NDC 50580-0228-49 Benadryl Allergy Liqui-Gels 25 mg/1 Details
Benadryl Allergy Liqui-Gels 25 mg/1
Benadryl Allergy Liqui-Gels is a ORAL CAPSULE, LIQUID FILLED in the HUMAN OTC DRUG category. It is labeled and distributed by Johnson & Johnson Consumer Inc.. The primary component is DIPHENHYDRAMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Diphenhydramine is used to relieve red, irritated, itchy, watery eyes; sneezing; and runny nose caused by hay fever, allergies, or the common cold. Diphenhydramine is also used to relieve cough caused by minor throat or airway irritation. Diphenhydramine is also used to prevent and treat motion sickness, and to treat insomnia (difficulty falling asleep or staying asleep). Diphenhydramine is also used to control abnormal movements in people who have early stage parkinsonian syndrome (a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) or who are experiencing movement problems as a side effect of a medication. Diphenhydramine will relieve the symptoms of these conditions but will not treat the cause of the symptoms or speed recovery. Diphenhydramine should not be used to cause sleepiness in children. Diphenhydramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 50580-0228-49Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Diphenhydramine
Product Information
| NDC | 50580-0228 |
|---|---|
| Product ID | 50580-228_fbdfb028-f11f-d968-e053-6294a90adcb4 |
| Associated GPIs | |
| GCN Sequence Number | 011582 |
| GCN Sequence Number Description | diphenhydramine HCl CAPSULE 25 MG ORAL |
| HIC3 | Z2P |
| HIC3 Description | ANTIHISTAMINES - 1ST GENERATION |
| GCN | 45971 |
| HICL Sequence Number | 004480 |
| HICL Sequence Number Description | DIPHENHYDRAMINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Benadryl Allergy Liqui-Gels |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | diphenhydramine hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIPHENHYDRAMINE HYDROCHLORIDE |
| Labeler Name | Johnson & Johnson Consumer Inc. |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50580-0228-49 (50580022849)
| NDC Package Code | 50580-228-49 |
|---|---|
| Billing NDC | 50580022849 |
| Package | 3 CARTON in 1 PACKAGE (50580-228-49) / 4 BLISTER PACK in 1 CARTON / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
| Marketing Start Date | 2023-06-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |